SCHEMBL5716787

SCHEMBL5716787

COc1ccc2[nH]c(-c3ccc(C=O)cc3)cc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.41
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
KDM4E B2RXH2 9/20 0.38
ALDH1A1 P00352 8/20 0.38
RAB9A P51151 6/20 0.38
SMN1; SMN2 Q16637 6/20 0.38
HPGD P15428 6/20 0.38
NPC1 O15118 5/20 0.38
MAPT P10636 4/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
BRD4 O60885 1/20 0.37
MEN1 O00255 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5716742 0.83 ERN1 (0.44) CLK1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL29956124 0.77 CYP2A6 (0.42) CLK1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL1788955 0.77 CYP2A6 (0.42) CLK1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL7608310 0.76 KDM4E (0.39) ADORA2AADORA1KDM4EALDH1A1RAB9A
SCHEMBL17919527 0.71 ALDH1A1 (0.43) KDM4EALDH1A1HPGDMAPTBRD4
SCHEMBL30081464 0.70 ALDH1A1 (0.46) ADORA1ALDH1A1HPGDMAPTKMT2A
SCHEMBL4586476 0.70 ALDH1A1 (0.46) ADORA1ALDH1A1HPGDMAPTKMT2A
SCHEMBL29377868 0.70 AXL (0.49) CLK1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL12614229 0.70 SIRT2 (0.46) CLK1ADORA2AADORA1KDM4EALDH1A1
SCHEMBL9959317 0.70 AXL (0.49) CLK1ADORA2AADORA1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1276720-B1 2-ACYL INDOL DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS BAXTER HEALTHCARE SA (CH) 2006-12-20 EP disclosed
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents BECKERS THOMAS (DE) 2002-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020091124-A1 2-acyl indole derivatives and their use as antitumor agents IDO1, IDO2, INMT CLK1 2130/4885ADORA2A 944/4885ADORA1 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.